Table 2.
Patient | Duration of Followup, mo | Diagnosis | Rejection | Relapse Posttransplant | Baseline Serum Creatinine, mg/dl | Serum Creatinine at 12 mo, mg/dl | Serum Creatinine at Last Followup, mg/dl |
---|---|---|---|---|---|---|---|
1 | 24 | WG | N | N | 0.7 | 0.8 | 0.8 |
2 | 60 | WG | N | Y | 1.2 | 1.6 | 1.4 |
3 | 52 | WG | N | Y | 1.3 | 1.6 | 1.7 |
4 | 37 | WG | Y | N | 1.0 | 1.3 | 5.7 |
5 | 79 | WG | N | N | 1.3 | 1.4 | 1.4 |
6 | 70 | WG | N | N | 1.2 | 1.1 | 1.2 |
7 | 73 | WG | N | N | 1.0 | 1.0 | 0.9 |
8 | 25 | WG | Y | N | 1.4 | 1.7 | 1.7 |
9 | 12 | WG | N | N | 1.5 | 1.5 | 1.5 |
10 | 93 | WG | N | N | 0.6 | 0.7 | 0.7 |
11 | 7 | WG | N | N | 1.0 | NA | 0.9 |
12 | 29 | MPA | N | N | 0.9 | 1.0 | 1.0 |
13 | 80 | MPA | N | Y | 1.7 | 1.8 | 1.6 |
14 | 25 | MPA | N | N | 1.5 | 1.5 | 1.5 |
15 | 32 | MPA | N | N | 1.0 | 1.1 | 0.9 |
16 | 27 | MPA | N | N | 1.1 | 1.1 | 1.1 |
17 | 24 | MPA | N | N | 1.1 | 1.1 | 0.9 |